[1] Stang A .2010 .Critical evaluation of the NewcastleOttawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol., 25(9) : 603-5.
[2] Sossdorf M,Otto GP,Boettel J,Winning J,Losche W .2013 .Benefit of low-dose aspirin and non-steroidal anti-inflammatory drugs in septic patients. Crit. Care, 17(1) : 402.
[3] Santos-Gallego CG,Badimon J .2021 .Overview of aspirin and platelet biology. Am. J. Cardiol., 144(Suppl 1) : S2-S9.
[4] Sokołowska P,Bleibel L,Owczarek J,WiktorowskaOwczarek A .2024 .PPARγ, NF-κB and the UPR pathway as new molecular targets in the antiinflammatory actions of NSAIDs: Novel applications in cancers and central nervous system diseases?. Adv. Clin. Exp. Med, 33(9) : 1007-1022.
[5] Tsai MJ,Ou SM,Shih CJ,Chao PW,Wang LF,Shih YN,Li SY,Kuo SC,Hsu YT,Chen YT .2015 .Association of prior antiplatelet agents with mortality in sepsis patients: A nationwide population-based cohort study. Intensive Care Med, 41(5) : 806-13.
[6] Rood KM,Patel N,DeVengencie IM,Quinn JP,Gowdy KM,Costantine MM,Kniss DA .2023 .Aspirin modulates production of pro-inflammatory and proresolving mediators in endothelial cells. PLoS One, 18(4) : e0283163.
[7] Rudd KE,Johnson SC,Agesa KM,Shackelford KA,Tsoi D,Kievlan DR,Colombara DV,Ikuta KS,Kissoon N,Finfer S,Fleischmann-Struzek C,Machado FR,Reinhart KK,Rowan K,Seymour CW,Watson RS,West TE,Marinho F,Hay SI,Lozano R,Lopez AD,Angus DC,Murray CJL,Naghavi M .1990 .Analysis for the global burden of disease study. Lancet, 395(10219) : 200-211.
[8] Pan Y,Cao S,Tang J,Arroyo JP,Terker AS,Wang Y,Niu A,Fan X,Wang S,Zhang Y,Jiang M,Wasserman DH,Zhang MZ,Harris RC .2022 .Cyclooxygenase-2 in adipose tissue macrophages limits adipose tissue dysfunction in obese mice. J. Clin. Invest, 132(9) : e152391.
[9] Ouyang Y,Wang Y,Liu B,Ma X,Ding R X .2019 .Effects of antiplatelet therapy on the mortality rate of patients with sepsis: A meta-analysis. J. Crit. Care, 50 : 162-168.
[10] Otto GP,Sossdorf M,Boettel J,Kabisch B,Breuel H,Winning J,Losche W .2013 .Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock. Platelets, 24(6) : 480-485.
[11] Nedeva C .2021 .Inflammation and cell death of the innate and adaptive immune system during sepsis. Biomolecules, 11(7) : 1011.
[12] Li X,Wang S,Ma J,Bai SG,Fu SZ .2024 .Predictive value of thrombocytopenia for bloodstream infection in patients with sepsis and septic shock. World J. Crit. Care Med, 13(1) : 88540.
[13] Leijte GP,Kiers D,van der Heijden W,Jansen A,Gerretsen J,Boerrigter V,Netea MG,Kox M,Pickkers P .2019 .Treatment with acetylsalicylic acid reverses endotoxin tolerance in humans in vivo: A randomized placebo-controlled study. Crit. Care Med, 47(4) : 508-516.
[14] Khoshbin E,Salehi R,Behroozi R,Sadr S,Zamani A,Farhadian M,Karkehabadi H M .2023 .The effect of low-dose aspirin on aspirin triggered lipoxin, interleukin 1 beta and prostaglandin E2 levels in periapical fluid: A double-blind randomized clinical trial. BMC Oral Health, 23(1) : 530.
[15] Kolawole OR,Kashfi K OR .2022 .NSAIDs and cancer resolution: New paradigms beyond cyclooxygenase. Int J Mol Sci., 23(3) : 1432.
[16] Jacobi J .2022 .The pathophysiology of sepsis - 2021 update: Part 2, organ dysfunction and assessment. Am. J. Health Syst. Pharm., 79(6) : 424-436.
[17] Hsu WT,Porta L,Chang IJ,Dao QL,Tehrani BM,Hsu TC,Lee CC .2022 .Association between aspirin use and sepsis outcomes: A national cohort study. Anesth, 135(1) : 110-117.
[18] Halushka PV,Wise WC,Cook JA .1981 .Protective effects of aspirin in endotoxic shock. J. Pharmacol. Exp. Ther., 218(2) : 464-469.
[19] Gonzalez DA,Kumar R,Asif S,Bali A,Dang AK .2022 .Sepsis and thrombocytopenia: A nowadays problem. Cureus., 14(5) : e25421.
[20] Eisen DP,Leder K,Woods RL,Lockery JE,McGuinness SL,Wolfe R,Pilcher D,Moore EM,Shastry A,Nelson MR,Reid CM,McNeil JJ,McBryde ES .2021 .Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): A randomised, double-blind, placebo-controlled primary prevention trial. Lancet Respir Med, 9(2) : 186-195.
[21] Evans L,Rhodes A,Alhazzani W,Antonelli M,Coopersmith CM,French C,Machado FR,Mcintyre L,Ostermann M,Prescott HC,Schorr C,Simpson S,Wiersinga WJ,Alshamsi F,Angus DC,Arabi Y,Azevedo L,Beale R,Beilman G,Belley-Cote E,Burry L,Cecconi M,Centofanti J,Coz Yataco A,De Waele J,Dellinger RP,Doi K,Du B,Estenssoro E,Ferrer R,Gomersall C,Hodgson C,Hylander Møller M,Iwashyna T,Jacob S,Kleinpell R,Klompas M,Koh Y,Kumar A,Kwizera A,Lobo S,Masur H,McGloughlin S,Mehta S,Mehta Y,Mer M,Nunnally M,Oczkowski S,Osborn T,Papathanassoglou E,Perner A,Puskarich M,Roberts J,Schweickert W,Seckel M,Sevransky J,Sprung CL,Welte T,Zimmerman J,Levy M .2021 .Crit Care Med. , 49(11) : e1063-e1143.
[22] Eisen DP,Reid D,McBryde ES D .2012 .Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis. Crit. Care Med, 40(6) : 1761-1767.
[23] Dony CA,Illipparambil LC,Maeda T,Mroczek SK,Rovitelli A,Wexler O,Malnoske M,Bice T,Fe AZ,Storms CR,Zhang J,Schultz RD,Pietropaoli AP .2023 .Plasma nitric oxide consumption is elevated and associated with adverse outcomes in critically ill patients. Crit. Care Med, 51(12) : 1706-1715.
[24] Chen S,Li S,Kuang C,Zhong Y,Yang Z,Yang Y,Liu F Y .2023 .Aspirin reduces the mortality risk of sepsisassociated acute kidney injury: An observational study using the MIMIC IV database. , 14 : 1186384.
[25] Chiu C and Legrand M .2021 .Epidemiology of sepsis and septic shock. Curr. Opin. Anaesthesiol., 34(2) : 71-76.
[26] Campbell R,McGuire A,Young L,Mackay A .2015 .Aspirin and statin therapy in sepsis, a red herring?. Intensive Care Medicine Experimental, 3 : 1-1.
[27] Bruno A,Tacconelli S,Contursi A,Ballerini P,Patrignani P .2023 .Cyclooxygenases and platelet functions. Adv. Pharmacol., 97 : 133-165.
[28] Al Harbi SA,Tamim HM,Al-Dorzi HM,Sadat M,Arabi YM M .2016 .Association between aspirin therapy and the outcome in critically ill patients: A nested cohort study. BMC Pharmacol, 17 : 5.
[29] Arita M,Yoshida M,Hong S,Tjonahen E,Glickman JN,Petasis NA,Blumberg RS,Serhan CN .2005 .-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. USA, 102(21) : 7671-7676.
[30] Valerio-Rojas JC,Jaffer IJ,Kor DJ,Gajic O,CartinCeba R O .2013 .Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: A historical cohort study. Crit. Care Res. Pract, 782573 : .
[31] Wiewel MA,van Vught LA,Frencken JF,Hoogendijk AJ,Klein Klouwenberg PMC,Horn J,Bonten MJ,Zwinderman AH,Cremer OL,Schultz MJ .2016 .Chronic antiplatelet therapy is not associated with alterations in the presentation, outcome, or host response biomarkers during sepsis: A propensity-matched analysis. Intensive Care Med, 42(3) : 352-360.
[32] Wang L,Li B,Zuo L,Pei F,Nie Y,Liu Y,Liu Z,Wu J,Guan X .2023 .Aspirin therapy and 28-day mortality in ICU patients: A retrospective observational study from two large databases. Clin. Ther, 45(4) : 316-332.